Bearish Monday: Sensex tumbles 500 points, mid-caps bleed; here are 3 reasons why

Bearish Monday: Sensex tumbles 500 points, mid-caps bleed; here are 3 reasons why

Geyatee Deshpande
/ Categories: Trending, DSIJ News

In the past few weeks, the domestic markets witnessed strong bullish sentiments. On Monday, bears charged ahead as Sensex declined by more than 500 points while Nifty fell by around 140 points.

While metal, auto, and IT stocks witnessed a sharp decline, the banking stocks also suffered losses. Bajaj Auto was down by 5.72 per cent, Tata Steel fell by 3.65 per cent, SBI was down by almost 3 per cent, etc.

On the other hand, Nestle India gained by more than 2 per cent as the company announced a 10 per cent increase in the revenue for Q3CY20. Its brands such as Maggi noodles & sauces, Munch, Nestle Classic, and Nescafe Sunrise saw double-digit growth during the quarter.

Weaker sentiments in the markets were due to –

  • Hiccups in Future-RIL deal

Singapore International Arbitration Centre (SIAC) passed an interim order asking Future Group to pause its plans of selling its retail business to RIL thus, dragging shares of RIL down by 3.15 per cent.

 

  • Increasing Coronavirus cases

A rise in Coronavirus cases was seen around the world with increased hospitalisations and deaths. As the second wave of COVID-19 is considered to have been erupted in Europe, Spain declared a state of emergency while France reported a sharp rise in the number of cases. US has also seen its highest-ever number of new COVID-19 cases in the past two days.

 

  • Panicky investors

The recent bullish sentiments in the markets have resulted in blue-chip stocks being just a few centimetres away from their record highs. Many scrips on BSE and NSE have already been recording strong gains. In such a situation, there is a risk of rising volatility, which seems to be panicking investors as the US elections are also round the corner.

Previous Article Buzzing stock: Tata Communications gains 5 per cent; touches 52-week high
Next Article Aurobindo Pharma rises on disposal of its US subsidiary
Rate this article:
4.4

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR